Article Type
Changed
Fri, 08/26/2022 - 01:26

Key clinical point: Endoscopic resection (ER) achieves favorable long-term survival outcomes in patients with early gastric cancer (EGC) in the real-world setting.

Major finding: The overall 5-year overall survival (OS) rate was 89.0% (95% CI 88.3%-89.6%). The lower limit of the 95% CI for the 5-year OS rate exceeded the threshold 5-year OS rate in all categories of pathological curability, including curative resection for expanded indications.

Study details: The data come from a multicenter prospective cohort study, J-WEB/EGC, that included 9054 patients with 10,021 EGC lesions who underwent ER.

Disclosures: This study was supported by the Japanese Ministry of Health, Labour, and Welfare, and Daiwa Securities Health Foundation. The authors declared no conflicts of interest.

Source: Suzuki H et al. Long-term survival after endoscopic resection for gastric cancer: Real-world evidence from a multicenter prospective cohort. Clin Gastroenterol Hepatol. 2022 (Aug 7). Doi: 10.1016/j.cgh.2022.07.029

Publications
Topics
Sections

Key clinical point: Endoscopic resection (ER) achieves favorable long-term survival outcomes in patients with early gastric cancer (EGC) in the real-world setting.

Major finding: The overall 5-year overall survival (OS) rate was 89.0% (95% CI 88.3%-89.6%). The lower limit of the 95% CI for the 5-year OS rate exceeded the threshold 5-year OS rate in all categories of pathological curability, including curative resection for expanded indications.

Study details: The data come from a multicenter prospective cohort study, J-WEB/EGC, that included 9054 patients with 10,021 EGC lesions who underwent ER.

Disclosures: This study was supported by the Japanese Ministry of Health, Labour, and Welfare, and Daiwa Securities Health Foundation. The authors declared no conflicts of interest.

Source: Suzuki H et al. Long-term survival after endoscopic resection for gastric cancer: Real-world evidence from a multicenter prospective cohort. Clin Gastroenterol Hepatol. 2022 (Aug 7). Doi: 10.1016/j.cgh.2022.07.029

Key clinical point: Endoscopic resection (ER) achieves favorable long-term survival outcomes in patients with early gastric cancer (EGC) in the real-world setting.

Major finding: The overall 5-year overall survival (OS) rate was 89.0% (95% CI 88.3%-89.6%). The lower limit of the 95% CI for the 5-year OS rate exceeded the threshold 5-year OS rate in all categories of pathological curability, including curative resection for expanded indications.

Study details: The data come from a multicenter prospective cohort study, J-WEB/EGC, that included 9054 patients with 10,021 EGC lesions who underwent ER.

Disclosures: This study was supported by the Japanese Ministry of Health, Labour, and Welfare, and Daiwa Securities Health Foundation. The authors declared no conflicts of interest.

Source: Suzuki H et al. Long-term survival after endoscopic resection for gastric cancer: Real-world evidence from a multicenter prospective cohort. Clin Gastroenterol Hepatol. 2022 (Aug 7). Doi: 10.1016/j.cgh.2022.07.029

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Article Series
Clinical Edge Journal Scan Commentary: Gastric Cancer, September 2022
Gate On Date
Wed, 06/22/2022 - 12:15
Un-Gate On Date
Wed, 06/22/2022 - 12:15
Use ProPublica
CFC Schedule Remove Status
Wed, 06/22/2022 - 12:15
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article